[1]
Steineck, G. and Glimelius, B. 2013. What is the appropriate use of palliative docetaxel in castration-resistant prostate cancer?. Acta Oncologica. 52, 8 (Nov. 2013), 1589–1592. DOI:https://doi.org/10.3109/0284186X.2013.821206.